收藏該雜志
同大類學(xué)科其它級(jí)別期刊:
中科院 1區(qū) 期刊 JCR Q1 期刊 中科院 2區(qū) 期刊 JCR Q2 期刊 中科院 3區(qū) 期刊 JCR Q3 期刊 中科院 4區(qū) 期刊 JCR Q4 期刊國際簡稱:JCO ONCOL PRACT 參考譯名:Jco 腫瘤學(xué)實(shí)踐
主要研究方向:ONCOLOGY 非預(yù)警期刊 審稿周期:
《Jco 腫瘤學(xué)實(shí)踐》(Jco Oncology Practice)是一本由LIPPINCOTT WILLIAMS & WILKINS出版的以O(shè)NCOLOGY為研究特色的國際期刊,發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章,及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn),旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊,近三年沒有被列入預(yù)警名單。
JCO Oncology Practice (JCO OP) publishes impactful information and insights to keep oncology practice current on changes and challenges inherent in delivering equitable, high-quality oncology care with an evolving value-based lens. All content dealing with understanding the provision of care—the mechanics of practice, care delivery, quality improvement, value, and equity—is the purview of JCO OP. JCO OP also addresses an expressed need by practicing physicians to have compressed, expert opinion addressing common clinical problems with perspectives by disease experts. JCO OP is a monthly journal, with a total of 12 issues per year. The Journal's ISSNs are 2688-1535 (online, version of record) and 2688-1527 (print)
JCO OP's content focuses on care delivery from various perspectives, including quality and value of care, improvement science, health services research, business and socioeconomics, performance of clinical trials, professionalism and ethics, and health policy. JCO OP's audience and contributors include all those involved in oncology care delivery, such as physicians, nurses, pharmacists, practice managers, business researchers, policy experts, and payers. Contributions address all settings of oncology care, including institutional, academic, and private practice. JCO OP strives to advance our profession's scientific tradition with new evidence to guide practice, since the details of delivery of care are critical to its quality. While the Journal often focuses on policy and delivery issues in the United States these topics know no geographical or philosophical borders, and all countries/health systems have insights to contribute.
| CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||||||||||
| 6.4 | 1.601 | 1.198 |
|
名詞解釋:CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù),是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年(含計(jì)算年度)的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如,2022年的 CiteScore 計(jì)算方法為:2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量 注:文獻(xiàn)類型包括:文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。
| Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
| 否 | 否 | 醫(yī)學(xué) | 3區(qū) | ONCOLOGY 腫瘤學(xué) | 3區(qū) |
| Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
| 否 | 否 | 醫(yī)學(xué) | 3區(qū) | ONCOLOGY 腫瘤學(xué) | 4區(qū) |
| Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
| 否 | 否 | 醫(yī)學(xué) | 3區(qū) | ONCOLOGY 腫瘤學(xué) | 4區(qū) |
| Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
| 否 | 否 | 醫(yī)學(xué) | 3區(qū) | ONCOLOGY 腫瘤學(xué) | 4區(qū) |
| Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
| 否 | 否 | 醫(yī)學(xué) | 3區(qū) | ONCOLOGY 腫瘤學(xué) | 4區(qū) |
| 按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學(xué)科:ONCOLOGY | SCIE | Q1 | 73 / 322 |
77.5% |
| 按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學(xué)科:ONCOLOGY | SCIE | Q2 | 113 / 322 |
65.06% |
Frontiers In Public Health
中科院 3區(qū) JCR Q2
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
Discover Oncology
中科院 4區(qū) JCR Q2
Bmc Psychiatry
中科院 2區(qū) JCR Q2
Journal Of Materials Chemistry B
中科院 3區(qū) JCR Q1
Bmc Neurology
中科院 3區(qū) JCR Q3
Medcomm
中科院 3區(qū) JCR Q1
若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商:TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103。